Search

Zai Lab Ltd ADR

Закрыт

СекторЗдравоохранение

25.08 0.4

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

24.73

Макс.

26.33

Ключевые показатели

By Trading Economics

Доход

191K

-51M

Продажи

6.7M

106M

Прибыль на акцию

-0.46

Рентабельность продаж

-47.808

Сотрудники

1,784

EBITDA

-2.1M

-46M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+48.76% upside

Дивиденды

By Acuity

Следующий отчет о доходах

5 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

914M

3B

Предыдущая цена открытия

24.68

Предыдущая цена закрытия

25.08

Новостные настроения

By Acuity

38%

62%

74 / 339 Рейтинг в Healthcare

Zai Lab Ltd ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

24 сент. 2026 г., 23:56 UTC

News

EUR/GBP rises as Germany's business expectations for September exceed forecasts, reaching 90.4 and indicating notable strength in today's performance.

24 сент. 2026 г., 23:55 UTC

News

LPL Financial reported total client assets of $2.60 trillion for August 2026, with the stock trading modestly lower in after-market hours.

24 сент. 2026 г., 23:55 UTC

News
Social Media

MGM Resorts International shares are modestly lower in after-market trading as it considers a bid for People Incorporated amid uncertain negotiations.

24 сент. 2026 г., 23:50 UTC

News

Regenxbio Inc. shares rose in after-market trading following positive three-year data for suragene lomparvovec, showing significant improvement in diabetic retinopathy patients.

24 сент. 2026 г., 23:46 UTC

News

Pentair PLC shares are trading lower in after-market hours amid a securities class action lawsuit alleging false statements about inventory issues affecting sales.

24 сент. 2026 г., 23:45 UTC

News

Global Payments Inc. is trading roughly flat in after-market hours, positioned below its 20-day moving average amid the Fed's announcement on cross-border transaction support.

24 сент. 2026 г., 23:45 UTC

News

EUR/NOK is trading higher as Germany's business expectations for September exceeded forecasts at 90.4, compared to the previous 89.

24 сент. 2026 г., 23:31 UTC

News

Celanese Corporation shares declined in after-market hours following the announcement of price increases for UHMW-PE and POM products, effective October 8, 2026.

24 сент. 2026 г., 23:30 UTC

Event
News

Merck & Co Inc's stock traded modestly lower in after-market hours following the announcement of Phase 2b/3 BRUNELLO trial results for diabetic macular edema.

24 сент. 2026 г., 23:21 UTC

News

CrowdStrike is collaborating with Snowflake to integrate its AI-native Falcon platform into the Snowflake Marketplace, with shares modestly higher in after-market trading.

24 сент. 2026 г., 23:16 UTC

Correlated Moves
News

Rockwell Automation shares traded lower in after-market hours following the announcement of Chief Revenue Officer Scott A. Genereux's retirement and Wells Fargo's Equal Weight rating.

24 сент. 2026 г., 23:16 UTC

News

EUR/JPY traded higher as Germany's September business expectations exceeded forecasts at 90.4, up from 89.3, contributing to modest gains in the currency pair.

24 сент. 2026 г., 23:06 UTC

News

General Electric Co has secured a $199.7 million contract for the R-391 Propeller Assembly, with shares modestly higher in after-market trading.

24 сент. 2026 г., 23:06 UTC

News

Wells Fargo analyst Joseph O'Dea initiated coverage on Otis Worldwide Corp with an Underweight rating, as shares traded roughly flat after market hours.

24 сент. 2026 г., 23:06 UTC

Social Media
News

GameStop's shares are trading lower in after-market hours despite CEO Ryan Cohen's reported share purchases, influenced by a broader market decline.

24 сент. 2026 г., 23:06 UTC

News
Event

Jabil Inc. shares are higher in after-market trading following a $1.7 billion contract manufacturing agreement with Akamai Technologies.

24 сент. 2026 г., 23:06 UTC

News

Delta Air Lines declared a quarterly dividend of $0.2150 per share, while its shares are declining in after-market trading amid broader market trends.

24 сент. 2026 г., 23:06 UTC

Social Media
News

Raises quarterly dividend to $1.17 per share

24 сент. 2026 г., 23:06 UTC

News

EUR/NZD is trading slightly higher as Germany's business expectations for September exceeded forecasts, coming in at 90.4, above the previous reading of 89.

24 сент. 2026 г., 23:06 UTC

Macro Event
News

The USD/NOK exchange rate is modestly higher, supported by lower U.S. initial jobless claims, reflecting recent macroeconomic developments.

24 сент. 2026 г., 23:06 UTC

Correlated Moves
News

U.S. natural gas storage levels reached 53 billion cubic feet, surpassing forecasts, while USD/ZAR trades modestly higher amid correlated movements with USD/MXN.

24 сент. 2026 г., 23:06 UTC

News

Newmont Corporation shares were roughly flat in after-market trading ahead of its Q3 2026 results announcement on October 22, 2026.

24 сент. 2026 г., 23:05 UTC

News

Vertiv Holdings Co shares rose in after-market hours after Wells Fargo initiated coverage with an Overweight rating and a $340.00 price target.

24 сент. 2026 г., 23:05 UTC

News

Automatic Data Processing Inc. is moving lower in after-market trading following the nomination of David W. Kenny and Nancy McKinstry to its Board of Directors.

24 сент. 2026 г., 23:05 UTC

News

Northrop Grumman Corp is trading roughly flat in after-market hours as the U.S. Air Force seeks input for replacing outdated radar systems.

24 сент. 2026 г., 23:01 UTC

News

nVent Electric PLC traded modestly lower in after-market hours following Wells Fargo's Equal Weight rating and $182.00 price target initiation by analyst Stephen Tusa.

24 сент. 2026 г., 23:01 UTC

News

AeroVironment Inc is declining in after-market trading despite securing a $464.8 million U.S. Army contract for its Enduring High Energy Laser program.

24 сент. 2026 г., 23:01 UTC

Social Media
News
Event

Costco reported fourth-quarter fiscal 2026 net sales of $93.9 billion and net income of $3.0 billion, exceeding expectations, with a slight increase in after-market trading.

24 сент. 2026 г., 23:01 UTC

News
Event

Scholastic Corp reported a fiscal Q1 net loss of $71.2 million and revenues of $216.8 million, prompting a sharp decline in shares after-market hours.

24 сент. 2026 г., 23:01 UTC

News

Starbucks plans to close about 250 locations, incurring $300 million in charges, while shares are modestly higher in after-market trading.

Сравнение c конкурентами

Изменение цены

Zai Lab Ltd ADR Прогноз

Целевая цена

By TipRanks

48.76% рост

Прогноз на 12 месяцев

Средняя 39.333 USD  48.76%

Максимум 45 USD

Минимум 36 USD

Основано на мнении 3 аналитиков Wall Street, спрогнозировавших целевые цены для Zai Lab Ltd ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

3 ratings

3

Покупка

0

Удержание

0

Продажа

Настроения

By Acuity

74 / 339Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.